| |
HORMONE DEFICIENCY TESTING
Diagnostic blood tests to identify disease risk factors that can be reversed before serious illness develops. Our blood testing service is designed for your maximum convenience, and you’ll save huge dollars in the process.
It’s easy. Get a clearer picture of your health in 3 simple steps .
Call 1-877-224-3633 or place your order online, and we'll set up an appointment for you at our local clinic or visit one of our authorized blood-drawing stations nationwide at your convenience. Results will be available within 7 - 10 working days after your blood is drawn. Receive a free consultation!
Once you receive your results, be sure to call our knowledgeable health advisors to help you understand them. Our expert team, including naturopathic doctors, nutritionists, and a Hormone Replacement Therapy specialist are ready assist you with any concerns, and can help you design a personalized health program. |
| | | • Reduce stress and anxiety • Enhance immune system • Increase strength and endurance • Reduce weight and body fat • Enhance cardiac output • Enhance sexual performance • Increase lean muscle • Lower blood pressure • Remove wrinkles and cellulite • Improve memory and mood • Improve metabolism • Cholesterol HDL/LDL balance
| |
| | |  Male HRT Panel
Female HRT Panel
FEMALE TEST PANEL
Chemistry Panel/CBC
This panel is a comprehensive blood evaluation consisting of 35 tests (Note: for more information see description listed under Chemistry Panel/CBC)
- Free Testosterone
This test is used to evaluate hirsutism and masculinization in women and to evaluate function in clinical states where the testosterone binding proteins may be altered (obesity, cirrhosis, thyroid disorders).
- Testosterone, Total
This test is used to evaluate gonadal and adrenal function.
- Dehydroepiandrosterone (DHEA) Sulfate
This test is used to determine female infertility, amenorrhea, or hirsutism and to aid in the evaluation of excess androgen/adrenocortical disease including congenital adrenal hyperplasia and adrenal tumors.
- Estradiol
This test is used to assess hypothalamic and pituitary functions, menopausal status, and sexual maturity.
- Progesterone
This test is used to establish the presence of a functional corpeus luteum or luteal cell function, confirm body temperature for occurrence of ovulation, obtain indication of day of ovulation, evaluate the functional state of corpeus luteum in experiencing infertility, assess placental function during pregnancy, and evaluate ovarian function.
- Insulin-Like Growth Factor I (IGF-1)
This test is used to determine acromegaly, in which Sm-C and GH are increased. It is also used to evaluate hypopituitarism. Somatomedin-C is a polypeptide hormone produced by the liver and other tissues, with effect on growth promoting activity and glucose metabolism (insulin-like activity). Somatomedin-C is carried in blood bound to a carrier protein which prolongs its half-life. Its level is therefore more constant than that of growth hormone. Low values are described with advanced age. Low values may indicate hypopituitarism, malnutrition, diabetes mellitus, Laron dwarfism, hypothyroidism, maternal deprivation syndrome, pubertal delay, cirrhosis, hepatoma, and some cases of short stature and normal GH response to pharmacologic tests. Low values may be found with nonfunctioning pituitary tumors, with constitutional delay of growth and development and with anorexia nervosa. High values occur with adolescence, true precocious puberty, pregnancy, obesity, pituitary gigantism, acromegaly and diabetic retinopathy. Since Sm-C is decreased with malnutrition, its concentration provides an index with which to monitor therapy for food deprivation
- Homocysteine
Homocysteine has been shown to be an independent risk factor for the premature development of coronary artery disease and thrombosis. This test is intended for use in screening individuals who may be at risk for heart disease and stroke.
Please Note: Studies have shown that even moderate levels of homocysteine pose an increased risk for arteriosclerosis compared with the lowest 20th percentile (< 7.2 pmol/L) of population controls.
- C-Reactive Protein (Cardiac)(High Sensitivity)
This test is used to assess risk of cardiovascular and peripheral vascular disease.
MALE TEST PANEL REVIEW
Chemistry Panel/CBC
This panel is a comprehensive blood evaluation consisting of 35 tests (see description listed under Chemistry Panel/CBC)
- Free Testosterone
This test is used to evaluate function in clinical states where the testosterone binding proteins may be altered (obesity, cirrhosis, thyroid disorders).
- Testosterone, Total
This test is used to evaluate gonadal and adrenal function. It is also helpful in diagnosing hypogonadism, hypopituitarism, Klinefelter's syndrome and impotence.
- Dehydroepiandrosterone (DHEA) Sulfate
This test is used to identify the source of excessive androgen (hirsutism and/or virilization), and in the identification of adrenocortical disease including congenital adrenal hyperplasia and adrenal tumors.
- Prostate-Specific Antigen (PSA)
PSA is produced by normal, hyperplastic, and cancerous prostatic tissue. Serum PSA has been found to be the most sensitive marker for monitoring individuals with prostate cancer and to enhance efficacy in monitoring progression of disease and response to therapy.
- Estradiol
This test is used to assess hypothalamic and pituitary functions. In males it is helpful in the assessment of gynecomastia or feminization syndromes.
- Insulin-Like Growth Factor I (IGF-1)
This test is used to determine acromegaly, in which Sm-C and GH are increased. It is also used to evaluate hypopituitarism. Somatomedin-C is a polypeptide hormone produced by the liver and other tissues, with effect on growth promoting activity and glucose metabolism (insulin-like activity). Somatomedin-C is carried in blood bound to a carrier protein which prolongs its half-life. Its level is therefore more constant than that of growth hormone. Low values are described with advanced age. Low values may indicate hypopituitarism, malnutrition, diabetes mellitus, Laron dwarfism, hypothyroidism, maternal deprivation syndrome, pubertal delay, cirrhosis, hepatoma, and some cases of short stature and normal GH response to pharmacologic tests. Low values may be found with nonfunctioning pituitary tumors, with constitutional delay of growth and development and with anorexia nervosa. High values occur with adolescence, true precocious puberty, pregnancy, obesity, pituitary gigantism, acromegaly and diabetic retinopathy. Since Sm-C is decreased with malnutrition, its concentration provides an index with which to monitor therapy for food deprivation
- Homocysteine
Homocysteine has been shown to be an independent risk factor for the premature development of coronary artery disease and thrombosis. This test is intended for use in screening individuals who may be at risk for heart disease and stroke. Studies have shown that even moderate levels of homocysteine pose an increased risk for arteriosclerosis compared with the lowest 20th percentile (<7.2 mcmol/L) of population controls.
- C-reactive protein (Cardiac) (High sensitivity)
This test is used to assess risk of cardiovascular and peripheral vascular disease
|
|
|
